Results 211 to 220 of about 2,482 (262)

Cellular mechanisms of long-term osmoregulation in magnocellular neurons. [PDF]

J Neuroendocrinol
Haan KD, Fisher TE.
europepmc   +1 more source

The Effect of Vasopressin on 90-Day Mortality in Patients With Cardiogenic Shock: A Retrospective Cohort Study Using Propensity Score-Weighted Analysis. [PDF]

Cardiovasc Ther
Beyls C, Hanquiez T, Mollet N, Sarfati Y, Zerima A, Chafiki S, Besserve P, Dupont H, Diouf M, Abou-Arab O, Mahjoub Y.   +10 more
europepmc   +1 more source

Intramuscular vasopressin: A feasible intervention for prehospital hemodynamic stabilization in porcine hemorrhagic shock and whole blood transfusion. [PDF]

Transfusion
Renberg M, Karlsson T, Gellerfors M, Gustavsson J, Wellfelt K, Günther M.   +5 more
europepmc   +1 more source

Vasopressin Initiation Timing and In-Hospital Mortality in Septic Shock: An Observational Study of Large Public Databases. [PDF]

Crit Care Explor
Sacha GL, Duggal A, Reddy AJ, Wang L, Bauer SR.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Vasopressin

Seminars in Respiratory and Critical Care Medicine, 2004
Vasopressin is a hormone that is essential for both osmotic and cardiovascular homeostasis. A deficiency of vasopressin exists in some shock states and replacement of physiological levels of vasopressin can restore vascular tone. Vasopressin is therefore emerging as a rational therapy for vasodilatory shock.
Cheryl L, Holmes, James A, Russell
openaire   +2 more sources

Vasopressin Antagonists

New England Journal of Medicine, 2015
info:eu-repo/semantics ...
Vandergheynst, Frederic, Gankam Kengne, Fabrice, Decaux, Guy   +2 more
openaire   +5 more sources

Effect of exogenous vasopressin on vasopressin release

American Journal of Physiology-Endocrinology and Metabolism, 1984
To characterize the influence of extracellular volume status on vasopressin pharmacokinetics, eleven young (aged 19-31 yr) and four old (aged 62-80 yr) subjects received bolus injections of 1 mU/kg Pitressin or synthetic arginine vasopressin following 6 days of sodium depletion (10 meq Na/day) or sodium loading (250 meq Na/day).
P A, Engel, J W, Rowe, K L, Minaker, G L, Robertson   +3 more
openaire   +2 more sources

Vasopressin and vasopressin receptors in brain edema

2020
Vasopressin is a peptide hormone produced in the hypothalamus and released from the posterior pituitary. Secretion of vasopressin is followed by activation of its receptors V1a, V1b, and V2 throughout the body. Each receptor type is responsible for a specific function of vasopressin.
Emil, Zeynalov, Susan M, Jones, J Paul, Elliott   +2 more
openaire   +2 more sources

Vasopressin antagonists

Cellular and Molecular Life Sciences, 2006
Effects of vasopressin via V1a- and V2-receptors are closely implicated in a variety of water-retaining diseases and cardiovascular diseases, including heart failure, hyponatraemia, hypertension, renal diseases, syndrome of inappropriate antidiuretic hormone secretion, cirrhosis and ocular hypertension.
Lemmens, Rosa, Kamyar, Majid-Reza
openaire   +2 more sources

Vasopressin in the ICU

Current Opinion in Critical Care, 2004
Vasopressin is one of the most important endogenously released stress hormones during shock. In this review, studies published in the past year that add to our understanding of the use of vasopressin in the ICU are discussed.Endogenous vasopressin levels are inappropriately low in adults with severe sepsis but not in children with meningococcal septic ...
Cheryl L, Holmes, Keith R, Walley
openaire   +2 more sources